THE "NEW" PROSTATE CANCER INFOLINK

A story on the New York Times “Well” blog, posted yesterday afternoon, provides a useful overview of the evolving spectrum of diagnostic/prognostic tests that can help to differentiate between truly low-risk and higher-risk, clinically significant prostate cancers.

The story (by Roni Rabin) doesn’t get into a lot of detail about all the new and development stage tests, but it does point out the way the world of testing for risk of clinically significant prostate cancer is changing, with less dependence being placed on the PSA test alone and greater dependence being placed on appropriate patient work-up prior to decisions about actual treatment or simple monitoring.

Filed under: Diagnosis, Risk | Tagged: Diagnosis, prognosis, risk, test |